[1]
|
Tanaka, A., Mori, M., Matsumoto, K., et al. (2019) Increase Trend in the Prevalence and Male-to-Female Ratio of Primary Biliary Cholangitis, Autoimmune Hepatitis, and Primary Sclerosing Cholangitis in Japan. Hepatology Research, 49, 881-889. https://doi.org/10.1111/hepr.13342
|
[2]
|
Werner, M., Prytz, H., Ohlsson, B., et al. (2008) Epidemiology and the Initial Presentation of Autoimmune Hepatitis in Sweden: A Nationwide Study. Scandinavian Journal of Gastroenterology, 43, 1232-1240. https://doi.org/10.1080/00365520802130183
|
[3]
|
Feld, J.J., Dinh, H., Arenovich, T., et al. (2005) Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome. Hepatology, 42, 53-62. https://doi.org/10.1002/hep.20732
|
[4]
|
Czaja, A.J. and Carpenter, H.A. (2004) Decreased Fibrosis during Corticosteroid Therapy of Autoimmune Hepatitis. Journal of Hepatology, 40, 646-652. https://doi.org/10.1016/j.jhep.2004.01.009
|
[5]
|
Van Den Brand Floris, F., Van Der Veen Koen, S., De Boer Ynto, S., et al. (2019) Increased Mortality among Patients with vs without Cirrhosis and Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology, 17, 940-947.E2. https://doi.org/10.1016/j.cgh.2018.09.046
|
[6]
|
Danielsson, B.Å., Marschall, H.-U., Bergquist, A., et al. (2017) Epidemiology and Causes of Death in a Swedish Cohort of Patients with Autoimmune Hepatitis. Scandinavian Journal of Gastroenterology, 52, 1022-1028. https://doi.org/10.1080/00365521.2017.1335772
|
[7]
|
Czaja, A.J. (2011) Performance Parameters of the Conventional Serological Markers for Autoimmune Hepatitis. Digestive Diseases and Sciences, 56, 545-554. https://doi.org/10.1007/s10620-010-1501-1
|
[8]
|
Abuaf, N., Lunel, F., Giral, P., et al. (1993) Non-Organ Specific Autoantibodies Associated with Chronic C Virus Hepatitis. Journal of Hepatology, 18, 359-364. https://doi.org/10.1016/S0168-8278(05)80281-8
|
[9]
|
Muratori, P., Czaja, A.J., Muratori, L., et al. (2007) Evidence of a Genetic Basis for the Different Geographic Occurrences of Liver/Kidney Microsomal Antibody Type 1 in Hepatitis C. Digestive Diseases and Sciences, 52, 179-184. https://doi.org/10.1007/s10620-006-9495-4
|
[10]
|
Strassburg, C.P., Obermayer-Straub, P., Alex, B., Durazzo, M., Rizzetto, M., Tukey, R.H., et al. (1996) Autoantibodies against Glucuronosyltransferases Differ between Viral Hepatitis and Autoimmune Hepatitis. Gastroenterology, 111, 1576-1586. https://doi.org/10.1016/S0016-5085(96)70020-3
|
[11]
|
Manns, M., Gerken, G., Kyriatsoulis, A., Staritz, M. and Meyer Zum Buschenfelde, K.H. (1987) Characterisation of a New Subgroup of Autoimmune Chronic Active Hepatitis by Autoantibodies against a Soluble Liver Antigen. The Lancet, 1, 292-294. https://doi.org/10.1016/S0140-6736(87)92024-1
|
[12]
|
Dalekos, G.N., Samakidou, A., Lyberopoulou, A., et al. (2022) Recent Advances in the Diagnosis and Management of Autoimmune Hepatitis. Polish Archives of Internal Medicine, 132, Article No. 16334. https://doi.org/10.20452/pamw.16334
|
[13]
|
Ma, Y., Bogdanos, D.P., Hussain, M.J., Underhill, J., Bansal, S., Longhi, M.S., et al. (2006) Polyclonal T-Cell Responses to Cytochrome P450IID6 Are Associated with Disease Activity in Autoimmune Hepatitis Type 2. Gastroenterology, 130, 868-882. https://doi.org/10.1053/j.gastro.2005.12.020
|
[14]
|
Zachou, K., Weiler-Normann, C., Muratori, L., et al. (2020) Permanent Immuno-Suppression in SLA/LP-Positive Autoimmune Hepatitis Is Required Although Overall Response and Survival Are Similar. Liver International, 40, 368-376. https://doi.org/10.1111/liv.14280
|
[15]
|
Vergani, D., Alvarez, F., Bianchi, F.B., Cancado, E.L., Mackay, I.R., Manns, M.P., et al. (2004) Liver Autoimmune Serology: A Consensus Statement from the Committee for Autoimmune Serology of the International Autoimmune Hepatitis Group. Journal of Hepatology, 41, 677-683. https://doi.org/10.1016/j.jhep.2004.08.002
|
[16]
|
Hennes, E.M., Zeniya, M., Czaja, A.J., et al. (2008) Simplified Criteria for the Diagnosis of Autoimmune Hepatitis. Hepatology, 48, 169-176. https://doi.org/10.1002/hep.22322
|
[17]
|
Gurung, A., Assis, D.N., McCarty, T.R., et al. (2018) Histologic Features of Autoimmune Hepatitis: A Critical Appraisal. Human Pathology, 82, 51-60. https://doi.org/10.1016/j.humpath.2018.07.014
|
[18]
|
De Boer, Y.S., Van Nieuwkerk, C.M., Witte, B.I., et al. (2015) Assessment of the Histopathological Key Features in Autoimmune Hepatitis. Histopathology, 66, 351-362. https://doi.org/10.1111/his.12558
|
[19]
|
Lohse, A.W., Sebode, M., Bhathal, P.S., et al. (2022) Consensus Recommendations for Histological Criteria of Autoimmune Hepatitis from the International AIH Pathology Group: Results of a Workshop on AIH Histology Hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. Liver International, 42, 1058-1069. https://doi.org/10.1111/liv.15217
|
[20]
|
Balitzer, D., Shafizadeh, N., Peters, M.G., Ferrell, L.D., Alshak, N. and Kakar, S. (2017) Autoimmune Hepatitis: Review of Histologic Features Included in the Simplified Criteria Proposed by the International Autoimmune Hepatitis Group and Proposal for New Histologic Criteria. Modern Pathology, 30, 773-783. https://doi.org/10.1038/modpathol.2016.267
|
[21]
|
Johnson, P.J. and McFarlane, I.G. (1993) Meeting Report: International Autoimmune Hepatitis Group. Hepatology, 18, 998-1005. https://doi.org/10.1002/hep.1840180435
|
[22]
|
Alvarez, F., Berg, P.A., Bianchi, F.B., et al. (1999) International Autoimmune Hepatitis Group Report: Review of Criteria for Diagnosis of Autoimmune Hepatitis. Journal of Hepatology, 31, 929-938. https://doi.org/10.1016/S0168-8278(99)80297-9
|
[23]
|
Czaja, A.J. (2008) Performance Parameters of the Diagnostic Scoring Systems for Autoimmune Hepatitis. Hepatology, 48, 1540-1548. https://doi.org/10.1002/hep.22513
|
[24]
|
Flikshteyn, B., Amer, K., Tafesh, Z., et al. (2024) Diagnosis of Autoimmune Hepatitis. Clinical Liver Disease, 28, 37-50. https://doi.org/10.1016/j.cld.2023.06.004
|
[25]
|
马雄, 王绮夏, 肖潇, 苗琪, 连敏, 唐茹琦, 尤红, 陆伦根, 韩英, 南月敏, 徐小元, 段钟平, 魏来, 贾继东, 庄辉.自身免疫性肝炎诊断和治疗指南(2021) [J]. 临床肝胆病杂志, 2022, 38(1): 42-49.
|
[26]
|
Muratori, P., Granito, A., Quarneti, C., et al. (2009) Autoimmune Hepatitis in Italy: The Bologna Experience. Journal of Hepatology, 50, 1210-1218. https://doi.org/10.1016/j.jhep.2009.01.020
|
[27]
|
Hartl, J., Denzer, U., Ehlken, H., et al. (2016) Transient Elastography in Autoimmune Hepatitis: Timing Determines the Impact of Inflammation and Fibrosis. Journal of Hepatology, 65, 769-775. https://doi.org/10.1016/j.jhep.2016.05.023
|
[28]
|
Yoshizawa, K., Matsumoto, A., Ichijo, T., et al. (2012) Long-Term Outcome of Japanese Patients with Type 1 Autoimmune Hepatitis. Hepatology, 56, 668-676. https://doi.org/10.1002/hep.25658
|
[29]
|
European Association for the Study of the Liver (2015) EASL Clinical Practice Guidelines: Autoimmune Hepatitis. Journal of Hepatology, 63, 971-1004. https://doi.org/10.1016/j.jhep.2015.06.030
|
[30]
|
Mack, C.L., Adams, D., Assis, D.N., et al. (2020) Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases. Hepatology, 72, 671-722. https://doi.org/10.1002/hep.31065
|
[31]
|
Pape, S., Gevers, T.J.G., Belias, M., et al. (2019) Predniso(Lo)Ne Dosage and Chance of Remission in Patients with Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology, 17, 2068-2075.E2. https://doi.org/10.1016/j.cgh.2018.12.035
|
[32]
|
Manns, M.P., Woynarowski, M., Kreisel, W., et al. (2010) Budesonide Induces Remission More Effectively than Prednisone in a Controlled Trial of Patients with Autoimmune Hepatitis. Gastroenterology, 139, 1198-1206. https://doi.org/10.1053/j.gastro.2010.06.046
|
[33]
|
Peiseler, M., Liebscher, T., Sebode, M., et al. (2018) Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients with Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology, 16, 260-267.E1. https://doi.org/10.1016/j.cgh.2016.12.040
|
[34]
|
Woynarowski, M., Nemeth, A., Baruch, Y., et al. (2013) Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents. The Journal of Pediatrics, 163, 1347-1353.E1. https://doi.org/10.1016/j.jpeds.2013.05.042
|
[35]
|
Liberal, R., De Boer, Y.S., Andrade, R.J., et al. (2017) Expert Clinical Management of Autoimmune Hepatitis in the Real World. Alimentary Pharmacology & Therapeutics, 45, 723-732. https://doi.org/10.1111/apt.13907
|
[36]
|
Lohse, A.W., Sebode, M., Jørgensen, M.H., et al. (2020) Second-Line and Third-Line Therapy for Autoimmune Hepatitis: A Position Statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. Journal of Hepatology, 73, 1496-1506. https://doi.org/10.1016/j.jhep.2020.07.023
|
[37]
|
Hübener, S., Oo, Y.H., Than, N.N., et al. (2016) Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients with Autoimmune Hepatitis and Azathioprine Intolerance. Clinical Gastroenterology and Hepatology, 14, 445-453. https://doi.org/10.1016/j.cgh.2015.09.037
|
[38]
|
Hennes, E.M., Oo, Y.H., Schramm, C., et al. (2008) Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis? American Journal of Gastroenterology, 103, 3063-3070. https://doi.org/10.1111/j.1572-0241.2008.02180.x
|
[39]
|
Nasseri-Moghaddam, S., Nikfam, S., Karimian, S., Khashayar, P. and Malekzadeh, R. (2013) Cyclosporine-A versus Prednisolone for Induction of Remission in Auto-Immunehepatitis: Interim Analysis Report of a Randomized Controlled Trial. Middle East Journal of Digestive Diseases, 5, 193-200.
|
[40]
|
Malekzadeh, R., Nasseri-Moghaddam, S., Kaviani, M.J., Taheri, H., Kamalian, N. and Sotoudeh, M. (2001) Cyclosporin A Is a Promising Alternative to Corticosteroids in Autoimmune Hepatitis. Digestive Diseases and Sciences, 46, 1321-1327. https://doi.org/10.1023/A:1010683817344
|
[41]
|
Van Thiel, D.H., Wright, H., Carroll, P., et al. (1995) Tacrolimus: A Potential New Treatment for Autoimmune Chronic Active Hepatitis: Results of an Open-Label Preliminary Trial. The American Journal of Gastroenterology, 90, 771-776.
|
[42]
|
中华医学会内分泌学分会, 中国内分泌代谢病专科联盟. 糖皮质激素类药物临床应用指导原则(2023版) [J]. 中华内分泌代谢杂志, 2023, 39(4): 289-296. https://doi.org/10.3760/cma.j.cn311282-20230116-00029
|
[43]
|
Wang, Z.Y., Sheng, L., Yang, Y., et al. (2017) The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review. Clinical Reviews in Allergy & Immunology, 52, 424-435. https://doi.org/10.1007/s12016-016-8583-2
|
[44]
|
Li, Y.-N., Ma, H., Zhou, L., et al. (2016) Autoimmune Hepatitis-Related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients. Chinese Medical Journal (England), 129, 2434-2440. https://doi.org/10.4103/0366-6999.191760
|
[45]
|
Yeoman, A.D., Westbrook, R.H., Zen, Y., et al. (2011) Early Predictors of Corticosteroid Treatment Failure in Icteric Presentations of Autoimmune Hepatitis. Hepatology, 53, 926-934. https://doi.org/10.1002/hep.24141
|
[46]
|
Schramm, C., Bubenheim, M., Adam, R., Karam, V., Buckels, J., O’Grady, J.G., et al. (2010) Primary Liver Transplantation for Autoimmune Hepatitis: A Comparative Analysis of the European Liver Transplant Registry. Liver Transplantation, 16, 461-469. https://doi.org/10.1002/lt.22018
|
[47]
|
Tapper, E.B. and Lok, A.S. (2017) Use of Liver Imaging and Biopsy in Clinical Practice. The New England Journal of Medicine, 377, 756-768. https://doi.org/10.1056/NEJMra1610570
|
[48]
|
Wu, S., Yang, Z., Zhou, J., Zeng, N., He, Z., Zhan, S., et al. (2019) Systematic Review: Diagnostic Accuracy of Non-Invasive Tests for Staging Liver Fibrosis in Autoimmune Hepatitis. Hepatology International, 13, 91-101. https://doi.org/10.1007/s12072-018-9907-5
|
[49]
|
Hartl, J., Ehlken, H., Sebode, M., et al. (2018) Usefulness of Biochemical Remission and Transient Elastography in Monitoring Disease Course in Autoimmune Hepatitis. Journal of Hepatology, 68, 754-763. https://doi.org/10.1016/j.jhep.2017.11.020
|
[50]
|
Laschtowitz, A., Zachou, K., Lygoura, V., et al. (2021) Histological Activity despite Normal ALT and IgG Serum Levels in Patients with Autoimmune Hepatitis and Cirrhosis. JHEP Reports, 3, Article ID: 100321. https://doi.org/10.1016/j.jhepr.2021.100321
|
[51]
|
Sharma, S., Agarwal, S., Kaushal, K., et al. (2021) Presence and Type of Decompensation Affects Outcomes in Autoimmune Hepatitis upon Treatment with Corticosteroids. JGH Open, 5, 81-90. https://doi.org/10.1002/jgh3.12451
|
[52]
|
Zhu, B., You, S.-L., Wan, Z.-H., et al. (2014) Clinical Characteristics and Corticosteroid Therapy in Patients with Autoimmune-Hepatitis-Induced Liver Failure. World Journal of Gastroenterology, 20, 7473-7479. https://doi.org/10.3748/wjg.v20.i23.7473
|